Aromatase Inhibitors and Plasma Lipid Changes in Postmenopausal Women with Breast Cancer: A Systematic Review and Meta-Analysis

Conclusions: Our results suggest that, despite statistically significant results, EXE and LET may not be sufficient to cause severe dyslipidemia in patients without cardiovascular comorbidities according to the AHA/ACC Guideline on the Management of Blood Cholesterol. However, the results may raise the question of monitoring the effects of AIs in patients, especially those with pre-existing cardiovascular risk factors such as dyslipidemia.PMID:38542042 | DOI:10.3390/jcm13061818

Source: Clinical Genitourinary Cancer - March 28, 2024 Category: Cancer & Oncology Authors: B álint Bérczi Nelli Farkas P éter Hegyi Barbara T óth Dezs ő Csupor Bal ázs Németh Anita Luk ács L ászló Márk Czumbel Be áta Kerémi Istv án Kiss Andrea Szab ó G ábor Varga G ábor Gerber Zolt án Gyöngyi Source Type: research